A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170. 1989

K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
Department of Radiology, Faculty of Medicine, Kyoto University.

The radiosensitizing activity, acute toxicity and pharmacokinetics of RP170, a new hypoxic cell radiosensitizer, were compared with those of misonidazole (MISO) and SR2508. RP170 belongs to the group of 2-nitroimidazole nucleosides, which are designed to be selectively excluded from the neural tissue. The reduction potential of RP170 was similar to that of MISO and SR2508. The partition coefficients in octanol/water of RP170, MISO, and SR2508 were 0.094, 0.35, and 0.021, respectively. The radiosensitizing activity of RP170 was similar to that of MISO and SR2508 in vitro and in vivo. There was no significant difference in the radiosensitizing activity of RP170 in vivo between intravenous and intraperitoneal administration. The acute toxicity of RP170 was the same as that of SR2508. Pharmacokinetic evaluation showed that the concentration of RP170 in the brain was as low as that of SR2508. RP170 is expected to have the same radiosensitizing effects as MISO and SR2508, and to be less neurotoxic than MISO.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008920 Misonidazole A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. Ro 07-0582,Ro 7-0582,alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol,Ro 07 0582,Ro 070582,Ro 7 0582,Ro 70582
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
April 1989, International journal of radiation oncology, biology, physics,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
January 1995, Oncology,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
July 1983, Rinsho hoshasen. Clinical radiography,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
July 1986, International journal of radiation oncology, biology, physics,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
January 1982, International journal of radiation oncology, biology, physics,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
March 1977, Radiology,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
April 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
July 1988, Biochemistry international,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
November 1982, British journal of cancer,
K Sasai, and Y Shibamoto, and M Takahashi, and M Abe, and J Wang, and L Zhou, and S Nishimoto, and T Kagiya
October 1988, Gan no rinsho. Japan journal of cancer clinics,
Copied contents to your clipboard!